BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Oct 31, 15:54Prev. Close
42.09
Open Price
42.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Balaxi Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 11.04 | 10.90 | 10.18 | 10.00 | 10.00 | |
| Total Share Capital | 11.04 | 10.90 | 10.18 | 10.00 | 10.00 | |
| Reserves and Surplus | 220.69 | 186.69 | 162.40 | 103.16 | 54.98 | |
| Total Reserves and Surplus | 220.69 | 186.69 | 162.40 | 103.16 | 54.98 | |
| Total Shareholders Funds | 231.74 | 201.36 | 182.88 | 113.16 | 64.98 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 21.24 | 0.00 | 0.87 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.90 | 1.00 | 0.00 | 0.04 | 0.01 | |
| Other Long Term Liabilities | 1.80 | 1.74 | 1.69 | 0.00 | 0.00 | |
| Long Term Provisions | 0.13 | 0.04 | 1.10 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 24.07 | 2.78 | 3.66 | 0.04 | 0.01 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 30.38 | 17.66 | 10.75 | 3.64 | 3.66 | |
| Trade Payables | 16.18 | 29.04 | 34.52 | 52.29 | 24.88 | |
| Other Current Liabilities | 7.97 | 7.50 | 7.86 | 0.09 | 0.14 | |
| Short Term Provisions | 0.00 | 0.00 | 0.00 | 7.25 | 6.01 | |
| Total Current Liabilities | 54.53 | 54.20 | 53.13 | 63.27 | 34.69 | |
| Total Capital And Liabilities | 310.34 | 258.34 | 239.67 | 176.47 | 99.68 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 14.24 | 14.78 | 16.18 | 5.46 | 1.17 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 22.07 | 2.31 | 2.83 | 0.57 | 0.00 | |
| Fixed Assets | 36.31 | 17.09 | 19.02 | 6.03 | 1.17 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 3.42 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 4.52 | 4.98 | 1.92 | 6.14 | 0.05 | |
| Total Non-Current Assets | 67.58 | 48.17 | 46.16 | 35.47 | 5.91 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 78.48 | 82.17 | 105.02 | 98.70 | 13.62 | |
| Trade Receivables | 110.80 | 55.71 | 52.28 | 28.62 | 76.76 | |
| Cash And Cash Equivalents | 39.40 | 62.29 | 28.22 | 7.19 | 1.67 | |
| Short Term Loans And Advances | 3.11 | 1.90 | 1.65 | 1.78 | 0.05 | |
| OtherCurrentAssets | 10.98 | 8.11 | 6.34 | 4.70 | 1.68 | |
| Total Current Assets | 242.77 | 210.17 | 193.51 | 141.00 | 93.77 | |
| Total Assets | 310.34 | 258.34 | 239.67 | 176.47 | 99.68 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 
12.08.2025
Balaxi Pharma Consolidated June 2025 Net Sales at Rs 70.74 crore, up 7.8% Y-o-Y
06.08.2025
Balaxi Pharma Standalone June 2025 Net Sales at Rs 16.71 crore, down 12.18% Y-o-Y
24.06.2025
Balaxi Pharma Standalone March 2025 Net Sales at Rs 9.65 crore, down 39.33% Y-o-Y
20.02.2025
Balaxi Pharma Consolidated December 2024 Net Sales at Rs 73.29 crore, up 20.57% Y-o-Y
12.08.2025
Balaxi Pharma Consolidated June 2025 Net Sales at Rs 70.74 crore, up 7.8% Y-o-Y
06.08.2025
Balaxi Pharma Standalone June 2025 Net Sales at Rs 16.71 crore, down 12.18% Y-o-Y
24.06.2025
Balaxi Pharma Standalone March 2025 Net Sales at Rs 9.65 crore, down 39.33% Y-o-Y
20.02.2025
Balaxi Pharma Consolidated December 2024 Net Sales at Rs 73.29 crore, up 20.57% Y-o-Y
15.06.2017
24.04.2017
18.04.2017
18.04.2017
14.02.2017
13.02.2017
12.02.2017
09.12.2016